Trial Profile
Phase II, randomised, single-center, open-label study of the efficacy of Ketek [telithromycin] in the treatment of lyme disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2006
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary) ; Amoxicillin
- Indications Lyme disease
- Focus Therapeutic Use
- 07 Nov 2006 New trial record.